Basilea Pharmaceutica Ltd Logo

Basilea Pharmaceutica Ltd (BPMUF)

OTC

Currency in USD
76.25
0.00 (0.00%)

Closed

Oct 6, 2026

Day's Range

76.25
76.25

52 wk Range

59.29
77.40

Overview - BPMUF - Basilea Pharmaceutica Ltd

Key Statistics

Valuation

Enterprise Value

1.05B

P/E (Trailing)

‪15.86‬

Price / Sales (TTM)

‪3.87‬

Price / Book

‪4.91‬

EV / EBITDA

‪14.28‬

Profitability

Profit Margin

‪21.17%‬

Operating Margin

‪26.89%‬

Return on Assets

‪13.68%‬

Return on Equity

‪39.45%‬

Ownership

Shares Outstanding

12.37M

Float

11.31M

Held by Insiders

‪0.61%‬

Held by Institutions

‪31.42%‬

Price stats

Beta

‪0.43‬

50-Day Avg

‪70.39‬

200-Day Avg

‪68.08‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

News Teaser - BPMUF - Basilea Pharmaceutica Ltd

News & Analysis

View all news

Market Cap - BPMUF - Basilea Pharmaceutica Ltd

Peers - BPMUF - Basilea Pharmaceutica Ltd

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - BPMUF - Basilea Pharmaceutica Ltd

About

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company headquartered in Allschwil, Switzerland, founded in 2000 as a spin-off from F. Hoffmann-La Roche. With approximately 150 employees, it focuses on discovering, developing, and commercializing innovative anti-infective drugs to address severe…

SectorHealthcare
IndustryBiotechnology
Employees180
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.